Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
10/1996
10/30/1996EP0647277A4 Methods for using cks fusion proteins.
10/17/1996WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/10/1996WO1996031625A1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/10/1996WO1996021465A3 Immunogenic conjugate molecules
10/10/1996CA2217641A1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/09/1996EP0735893A1 Alteration of immune response using pan dr-binding peptides
10/08/1996US5563056 Forming a matrix having first chemical species covalently immobilized and includes free molecules of second chemical species, gradually releasing the second species molecule from matrix
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/03/1996WO1996030409A1 Method for immobilisation of proteins and polyelectrolytes on surfaces of solids
10/02/1996EP0734530A1 Combinatorial libraries and methods for their use
10/01/1996CA1338619C Lectin complex and method and probe for making same
09/1996
09/25/1996EP0733903A1 Immunoassay for the detection of urinary cortisol and reagents therefor
09/25/1996EP0733213A1 Process for the production of combinatorial compound libraries
09/25/1996EP0733126A1 Immobilized mismatch binding protein for detection or purification of mutations or polymorphisms
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0732939A1 Preparation and use of immunoconjugates
09/25/1996EP0502050B1 A protein purification method
09/25/1996CA2172451A1 Process for the immunologic determination of cortisol, especially urinary cortisol, and reagents used
09/24/1996US5559213 Polyethylene-protein conjugates
09/18/1996EP0731915A1 Prenatal detection of meconium
09/17/1996US5556623 Inhibiting neoplasm growth in mammal by parenterally administering immunoconjugate of antibody or antigen-binding fragment thereof with beta-alanine whose amino is converted to drug derivative-substituted methylene amide
09/12/1996WO1996027657A1 Cell growth substrates with tethered cell growth effector molecules
09/12/1996WO1996027614A1 Surface modified affinity separation membrane
09/11/1996EP0730470A1 Improved interferon polymer conjugates
09/11/1996EP0713423A4 Composite biological-molecule-accretion material
09/11/1996EP0381719B1 Cellulose binding fusion proteins
09/05/1996DE4436173C1 Hydrophobically modified matrix surface for bio-sensor etc.
08/1996
08/28/1996EP0728015A1 Combinatorial polypeptide antigens
08/28/1996EP0728012A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
08/21/1996EP0727438A2 Adducts of PEG and GM-CSF
08/21/1996EP0727437A2 Covalent PEG-protein adducts
08/20/1996US5548064 Colony stimulating factor; oral administering
08/20/1996US5547839 Contacting polynucleotides with surface of solid substrate, hybridizing using nucleic acid polymerase and labeled nucleotide
08/14/1996EP0726288A1 Carboxylic acid modified polyethylene membranes
08/14/1996EP0726276A1 PEPTIDE CONTAINING AMINO ACID SEQUENCE OF FIMBRIAL PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) AND USE THEREOF
08/14/1996EP0396559B1 Hiv peptides, artificial hiv antigens and immunoassay kits
07/1996
07/30/1996CA1338502C Solid support chemistry system
07/25/1996WO1996009805A3 Chitosan induced immunopotentiation
07/24/1996EP0665850A4 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions.
07/24/1996EP0555336B1 Homobifunctional agents for coupling enzymes and the like to antibodies and the like
07/23/1996US5539063 Polymer for making poly(ethylene glycol)-protein conjugates
07/23/1996US5538946 Hirudin derivatives with delayed action
07/18/1996WO1996021675A2 Capturing of microorganisms using complement components
07/18/1996WO1996021465A2 Immunogenic conjugate molecules
07/10/1996CN1126441A Amplification of the vitamin B12 uptake system using polymers
07/10/1996CN1126436A Vitamin B12 mediated oral delivery systems for GCSF and EPO
07/09/1996US5534494 Polypeptide compounds having growth hormone releasing activity
07/04/1996WO1996020403A1 Assay, receptor proteins and ligands
07/04/1996CA2208319A1 Assay, receptor proteins and ligands
06/1996
06/26/1996EP0718308A2 Peptide derivatives having binding activity to modified low density lipoprotein
06/25/1996US5529915 Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin
06/19/1996EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY
06/18/1996US5527713 Consisting of t-cell specific antibodies covalently bound to amine groups present on water soluble aminodextran
06/18/1996US5527681 Immobilized molecular synthesis of systematically substituted compounds
06/13/1996WO1996018059A1 Functionalized fibrils
06/12/1996EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity
06/06/1996WO1996016983A1 Cooperative combinations of ligands contained within a matrix
06/06/1996CA2206175A1 Cooperative combinations of ligands contained within a matrix
05/1996
05/29/1996EP0713423A1 Composite biological-molecule-accretion material
05/28/1996CA2078996C A bifunctional dtpa-type ligand
05/26/1996CA2136697A1 Resin compositions and methods for their use
05/22/1996EP0712313A1 Pro-cytotoxic drug conjugates for anticancer therapy
05/15/1996EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy
05/15/1996CN1122577A Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
05/09/1996WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996WO1996013161A1 Creating an aerosolized formulation of insulin
05/09/1996CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/08/1996EP0710244A1 Immunoreactive reagents employing monoamine oxidase
05/08/1996EP0365646B1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
05/07/1996US5514598 Prenatal detection of meconium
05/07/1996US5514581 Functional recombinantly prepared synthetic protein polymer
05/02/1996WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/01/1996CN1121725A Immunoparticles bearing monoclonal anti-CD4 antibodies and utilisation thereof
04/1996
04/25/1996WO1996011953A1 N-terminally chemically modified protein compositions and methods
04/25/1996CA2472085A1 N-terminally chemically modified protein compositions and methods
04/25/1996CA2202382A1 Tc or re radiolabelled somatostatin analogs
04/23/1996US5510270 Generating pattern of light and dark areas by selectively irradiating surface areas; deprotecting; contacting with receptor to identify oligonucleotide showing complementarity to receptor
04/23/1996US5510240 Method of screening a peptide library
04/18/1996WO1996011403A1 Process for immobilizing bio-material on a substrate
04/18/1996CA2202034A1 Process for immobilizing biomaterial on a substrate
04/17/1996CN1120467A Prodn. of carbon molecular sieve from nut shell (seed) for producing nitrogen by air separation
04/17/1996CN1120457A Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
04/10/1996EP0705279A1 Topologically segregated, encoded solid phase libraries
04/04/1996WO1996009805A2 Chitosan induced immunopotentiation
04/04/1996CA2200550A1 Chitosan induced immunopotentiation
04/03/1996EP0703926A1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
03/1996
03/27/1996EP0702793A1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation
03/26/1996US5502037 Antitumor agents for procytotoxic drugs
03/21/1996WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996CA2198361A1 Intracellular delivery of chemical agents to a specific cell type
03/20/1996EP0701448A1 Amplification of the vitamin b 12? uptake system using polymers
03/20/1996EP0546032B1 Immobilization of organic macromolecules or biopolymers in a polymer membrane
03/20/1996EP0449973B1 Polypeptide-polymer conjugates active in wound healing
03/19/1996US5500348 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators
03/14/1996WO1996007670A1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
03/14/1996CA2199387A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
03/13/1996EP0701130A2 Device and process for cell capture and recovery
03/13/1996EP0700302A1 Method of treating diabetes mellitus